Canadian Agency for Drugs and Technologies in Health. (2017). Pharmacoeconomic review report: Sarilumab (Kevzara). CADTH.
Chicago Style (17th ed.) CitationCanadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Sarilumab (Kevzara). Ottawa (ON): CADTH, 2017.
MLA (9th ed.) CitationCanadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report: Sarilumab (Kevzara). CADTH, 2017.
Warning: These citations may not always be 100% accurate.